"Synergistic Potential of Linagliptin and Resveratrol in Mitigating Type-II Diabetes-Induced Nephropathy": A Comprehensive Review [0.03%]
Prashant Ghimiray,P R Anand Vijayakumar,G R Meghna et al.
Prashant Ghimiray et al.
This narrative review aims to elucidate the significance of the synergistic effects of linagliptin and resveratrol and also explores their individual mechanisms of action in diabetic complications such as nephropathy. A systematic literatur...
Transcription Factors in Type 2 Diabetes: Molecular Mechanisms of Insulin Resistance and β-Cell Dysfunction [0.03%]
Seyyed Amin Seyyed Rezaei,Akbar Amirfiroozi,Moein Kohkalani et al.
Seyyed Amin Seyyed Rezaei et al.
Type 2 diabetes mellitus (T2DM) is a common global disease affecting more than 588 million people. This number is projected to reach 852 million by 2050, imposing a significant socioeconomic burden. Type 2 diabetes results from insulin resi...
Potential Involvement of Fructosylated Human Insulin and Serological Evidence in Subclinical Autoimmune Activity in Type 2 Diabetes Mellitus [0.03%]
Ali Raza,Safia Habib,Saba Noor et al.
Ali Raza et al.
Introduction: Type 2 Diabetes Mellitus (T2DM) involves chronic inflammation and recurrent hyperglycemia, often linked to excessive fructose intake. Some patients develop autoantibodies, indicating immune dysfunction. Fruc...
Antibiotics and Metabolic Dysregulation After Surgery: Exploring an Overlooked Connection [0.03%]
抗生素与手术后的代谢紊乱：探讨一个被忽视的联系
Dinesh Kumar,Vrinda Gupta,Nicky Kumar Jaiswal et al.
Dinesh Kumar et al.
Hypertension and hyperglycemia are common in patients without metabolic disease even after surgery and are generally considered to have been caused by surgical stress and inflammation. Nonetheless, in the case of long-term or repeated expos...
Automated Insulin Delivery for Patients with Type 2 Diabetes: A Narrative Review [0.03%]
自动胰岛素输送在2型糖尿病患者中的应用：叙述性综述
Konstantinos Kitsios,Christina-Maria Trakatelli
Konstantinos Kitsios
Despite the availability of newer antidiabetic medications, many patients with type 2 diabetes mellitus still do not achieve their glycemic targets and require insulin treatment. Research from a limited number of randomized controlled trial...
The Global Burden of Type 2 Diabetes Attributable to Dietary Risks Among Women: A 1990-2021 Analysis and Forecasting Through 2050 [0.03%]
1990-2021年全球饮食风险因素导致的女性2型糖尿病疾病负担分析及至2050年的预测
Tao Ding,Xiaoling Wang,Puwen Chen et al.
Tao Ding et al.
Type 2 diabetes (T2D) is one of the major contributors to global mortality and disability. Diet and gender are key aspects of T2D, yet limited attention has been given to how their intersection contributes to the T2D disease burden. This st...
COVID-19 Impact on Lipid Profile and Metabolome in Patients with Type 2 Diabetes Mellitus: Mini-Review [0.03%]
冠状肺炎对2型糖尿病患者的脂质谱和代谢组的影响：综述文章
Karolina Pawłuszkiewicz,Anita Maria Faltus,Gabriela Augustynowicz et al.
Karolina Pawłuszkiewicz et al.
Aim: This review aims to explore the pathophysiological mechanisms by which SARS-- CoV-2 affects lipid metabolism and the metabolome in patients with Type 2 Diabetes Mellitus (T2DM). It compares these alterations with tho...
Metabolomics-Based Study: Effects of Fructose, Glucose, and Mannose on Islet Cells and Change of Serum Markers in Streptozotocin-Induced Diabetic Rats [0.03%]
基于代谢组学的研究：果糖、葡萄糖和甘露糖对胰岛细胞的影响及链脲佐菌素诱导的糖尿病大鼠血清标志物的变化
Shuang Guo,Tao Liu,Rong Li et al.
Shuang Guo et al.
Introduction: experiment uses metabolomics to explore the effects of glucose, fructose, and mannose on the metabolism and pancreatic islet structure of rats, providing ideas and references for clinical and practical appli...
Role of Nephropathological Factors with Fibrinogen in the Progression of Human Diabetic Nephropathy in the Pakistani Population [0.03%]
纤粘蛋白在糖尿病肾病发病机制中的作用及其与肾脏病理因素的关联性研究
Maha Maqsood,Saima Sharif,Muhammad Saqib et al.
Maha Maqsood et al.
Introduction: Fibrinogen is synthesized in the liver and is a marker of acute-phase inflammation. It is essential for regulating the inflammatory response by attaching to receptors on the surfaces of many cells and is inv...
Comparative Clinical and Metabolic Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 1 Diabetes: A Retrospective Cohort Study from Saudi Arabia [0.03%]
一项来自沙特阿拉伯的回顾性队列研究：比较1型糖尿病患者中胰高血糖素样肽-1受体激动剂与钠-葡萄糖共转运蛋白2抑制剂的临床及代谢结局
Ayman Al Hayek,Asirvatham Alwin Robert,Abdullah Khalid Al Burayk et al.
Ayman Al Hayek et al.
Introduction: This research is designed to compare the clinical characteristics, metabolic outcomes, and safety profiles of patients with Type 1 Diabetes (T1D) treated with Glucagon-Like Peptide-1 Receptor Agonists (GLP-1...